BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,046 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $346,110 | -26.0% | 10,347 | -5.5% | 0.02% | -24.2% |
Q1 2024 | $467,850 | +15.5% | 10,946 | +4.5% | 0.03% | +6.5% |
Q4 2023 | $405,119 | +2.3% | 10,479 | -0.1% | 0.03% | -6.1% |
Q3 2023 | $395,870 | -22.9% | 10,489 | -7.0% | 0.03% | -21.4% |
Q2 2023 | $513,612 | +12.4% | 11,273 | +0.1% | 0.04% | +10.5% |
Q1 2023 | $456,889 | +55.7% | 11,265 | +95.6% | 0.04% | +46.2% |
Q4 2022 | $293,464 | -5.0% | 5,758 | +0.5% | 0.03% | -13.3% |
Q3 2022 | $309,000 | -16.0% | 5,731 | +0.1% | 0.03% | -9.1% |
Q2 2022 | $368,000 | -17.1% | 5,726 | +0.1% | 0.03% | -5.7% |
Q1 2022 | $444,000 | -9.6% | 5,722 | +0.1% | 0.04% | +2.9% |
Q4 2021 | $491,000 | +1.9% | 5,718 | -4.5% | 0.03% | -12.8% |
Q3 2021 | $482,000 | 0.0% | 5,990 | +0.1% | 0.04% | +2.6% |
Q2 2021 | $482,000 | -4.6% | 5,985 | +0.1% | 0.04% | -20.8% |
Q1 2021 | $505,000 | +5.2% | 5,982 | +0.1% | 0.05% | -4.0% |
Q4 2020 | $480,000 | 0.0% | 5,978 | +0.1% | 0.05% | -12.3% |
Q3 2020 | $480,000 | -6.6% | 5,975 | +0.1% | 0.06% | -14.9% |
Q2 2020 | $514,000 | -5.5% | 5,971 | -10.9% | 0.07% | -16.2% |
Q1 2020 | $544,000 | -8.0% | 6,698 | -5.2% | 0.08% | +29.0% |
Q4 2019 | $591,000 | -8.7% | 7,065 | -4.6% | 0.06% | -13.9% |
Q3 2019 | $647,000 | +13.5% | 7,402 | +6.4% | 0.07% | +9.1% |
Q2 2019 | $570,000 | +0.7% | 6,959 | +0.0% | 0.07% | 0.0% |
Q1 2019 | $566,000 | +23.6% | 6,956 | +0.0% | 0.07% | +10.0% |
Q4 2018 | $458,000 | -14.6% | 6,953 | +0.0% | 0.06% | 0.0% |
Q3 2018 | $536,000 | +25.2% | 6,950 | +20.0% | 0.06% | +20.0% |
Q2 2018 | $428,000 | +16.6% | 5,791 | +2.7% | 0.05% | +13.6% |
Q1 2018 | $367,000 | +0.5% | 5,641 | 0.0% | 0.04% | 0.0% |
Q4 2017 | $365,000 | -6.6% | 5,641 | -9.4% | 0.04% | -12.0% |
Q3 2017 | $391,000 | +3.7% | 6,226 | 0.0% | 0.05% | 0.0% |
Q2 2017 | $377,000 | +32.7% | 6,226 | +13.7% | 0.05% | +28.2% |
Q1 2017 | $284,000 | +26.2% | 5,478 | +7.9% | 0.04% | +14.7% |
Q4 2016 | $225,000 | -7.0% | 5,078 | 0.0% | 0.03% | -20.9% |
Q3 2016 | $242,000 | +5.2% | 5,078 | 0.0% | 0.04% | +2.4% |
Q2 2016 | $230,000 | +10.0% | 5,078 | 0.0% | 0.04% | +5.0% |
Q1 2016 | $209,000 | +1.0% | 5,078 | -6.4% | 0.04% | 0.0% |
Q4 2015 | $207,000 | +158.8% | 5,428 | +123.6% | 0.04% | +150.0% |
Q3 2015 | $80,000 | -52.9% | 2,428 | 0.0% | 0.02% | -48.4% |
Q2 2015 | $170,000 | +1.8% | 2,428 | -0.4% | 0.03% | 0.0% |
Q1 2015 | $167,000 | -6.2% | 2,438 | +0.4% | 0.03% | -8.8% |
Q4 2014 | $178,000 | +2.3% | 2,428 | 0.0% | 0.03% | -2.9% |
Q3 2014 | $174,000 | -1.1% | 2,428 | 0.0% | 0.04% | 0.0% |
Q2 2014 | $176,000 | -1.7% | 2,428 | 0.0% | 0.04% | -5.4% |
Q1 2014 | $179,000 | – | 2,428 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |